humalog 100unitsml solution for injection 3ml cartridges
eli lilly and company ltd - insulin lispro - solution for injection - 100unit/1ml
humalog mix50 100unitsml suspension for injection 3ml cartridges
eli lilly and company ltd - insulin lispro; insulin lispro protamine - suspension for injection - 50unit/1ml ; 50unit/1ml
humalog kwikpen 100unitsml solution for injection 3ml pre-filled pen
eli lilly and company ltd - insulin lispro - solution for injection - 100unit/1ml
humalog mix25 kwikpen 100unitsml suspension for injection 3ml pre-filled pen
eli lilly and company ltd - insulin lispro; insulin lispro protamine - suspension for injection - 25unit/1ml ; 75unit/1ml
humalog mix50 kwikpen 100unitsml suspension for injection 3ml pre-filled pen
eli lilly and company ltd - insulin lispro; insulin lispro protamine - suspension for injection - 50unit/1ml ; 50unit/1ml
humalog mix25 100unitsml suspension for injection 10ml vials
eli lilly and company ltd - insulin lispro protamine; insulin lispro - suspension for injection - 75unit/1ml ; 25unit/1ml
humalog kwikpen 200unitsml solution for injection 3ml pre-filled pen
eli lilly and company ltd - insulin lispro - solution for injection - 200unit/1ml
insulin lispro sanofi
sanofi winthrop industrie - insulin lispro - diabetes mellitus - drugs used in diabetes - for the treatment of adults and children with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis. insulin lispro sanofi is also indicated for the initial stabilisation of diabetes mellitus.
humalog mix 50
lilly france s.a.s. - 50% insulin lispro solution and 50% insulin lispro protamine suspension (recombinant dna) - suspension for s/c injection - 100iu/ml (3,5mg/ml)
venofer iron 100mg/5ml (as iron(iii) hydroxide sucrose complex) injection
seqirus pty ltd - iron sucrose, quantity: 540 mg/ml (equivalent: iron, qty 20 mg/ml) - injection, concentrated - excipient ingredients: sodium hydroxide; water for injections - venofer is indicated for the treatment of iron deficiency anaemia in patients undergoing chronic haemodialysis and who are receiving supplemental erythropoietin therapy.,the diagnosis of iron deficiency must be based on appropriate laboratory tests (e.g. serum ferritin, serum iron, transferrin saturation and hypochromic red cells).